Use of vitamin A cream may prevent s...( ant local destruction and disfigurement...)

Use of vitamin A cream may prevent skin cancer

ant local destruction and disfigurement if neglected or treated inadequately. Prognosis is excellent with proper therapy.

An estimated cancer one million new cases of skin cancer will be diagnosed in United States and an estimated 9,600 cancer deaths (7,400 from melanoma, 2,200 from other forms of skin cancer) will occur in 2002, according the American Cancer Society. The rate of melanoma mortality in men has recently increased, but has been stable for women, and the incidence of skin cancer is 10 times higher in Caucasians than in African-Americans. The five-year survival rate for melanoma is 89 percent; about 82 percent of melanomas are diagnosed at a localized stage.

'"/>

Contact: Aimee Frank
AMF@spectrumscience.com
202-369-1654
American Association for Cancer Research
16-Oct-2002

Page: 1 2
Related biology news :

1. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
2. Chemical derived from vitamin-E shows early promise as cancer drug
3. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
4. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
5. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
6. New antioxidants are 100 times more effective than vitamin E
7. Study finds huge variability in vitamin E absorption
8. People with undetermined muscle/bone pain tend to be severely vitamin D deficient
9. Daily vitamins could prevent vision loss among thousands
10. Drug that mimics vitamin D hormone may boost effectiveness of prostate cancer treatment
11. Strategies to boost womens multivitamin use fall short

Post Your Comments:

(Date:11/23/2009)...RE, Calif. - By producing some of the highest reso...faces, scientists have a deeper understanding how ...research may lead to a new treatment for kidney st...ppears in the Nov. 23 online edition of the journa... , explores how peptides interact with mineral sur...

(Date:11/23/2009)...MINGHAM, Ala. A new study by University of Alabam...mass index (BMI) and co-existing medical condition...ival observed among African-Americans compared to ...s published online Nov. 23 in Cancer , a journal ...dicates that although BMI and co-morbidity are ind...

(Date:11/23/2009)...GN, Ill. Two new studies reveal in unprecedented ...ules to assemble new proteins and guide them towar...es used molecular dynamics flexible fitting (MDFF)...wo prominent molecular partners. , The first st...iences , concerns the intimate signaling between t...

[0] Scientists watch as peptides control crystal growth with 'switches, throttles and brakes'[0] Racial disparity in colon cancer survival not easily explained, UAB researchers say [0] Computational microscope peers into the working ribosome

(Date:11/24/2009)...ntly approved the Promega PowerPlex 16 HS System f...ing DNA records for the National DNA Index System....) -- The FBI recently approved the Promega PowerP...ticipating in, or generating DNA records for, the ...ontains more than seven million profiles and has a...

(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...

(Date:11/24/2009)...ire/--HealthRoboticstodayannounced,thatithasformed...tors.ThisrecentlyformedToronto-basedcompanywillope...arket,install,andsupport,HealthRobotics,i.v.Roomof...ductofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(T...nceonan"asneeded,basis"toitsstrategicpartnershipsw...

(Date:11/24/2009)...tCall/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CT...yHealthCareConference.TheconferencewillbeheldDecem...presentonTuesday,December1at11:00a.m.EasternTimein...tionwillbeavailableat www.celltherapeutics.com ,an...erJaffrayHealthCareConference,NewYorkPalaceHotel,H...

Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3 Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2

[0] NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease [0] Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada [0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference

Other News:

...ole in the molecular machinery for making HIV-1 (t...scientists from the National Institute of Standard... working at the Center for Advanced Research in Bi...the mechanism, described in the Jan. 20 online edi...

...the Stanford Synchrotron Radiation Laboratory (SSR...acility, SPEAR3, guarantees a world-class program ...retary of Energy Spencer Abraham. "This is the fir...Institutes of Health have joined in funding an acc...

..., Low Cholesterol Diets......It is well known that...reased risk for coronary heart disease a major ca...erapeutic approach is to follow a diet low in satu...fect of this therapeutic diet on cholesterol respo...

...launched a new initiative to speed research on ner... that attacks the brain and spinal cord. The Socie...mpete for grants of up to $5.5 million each to pav...ction strategies in people with MS. ......"The pac...

Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 2 Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory 3 Highlights of Tufts University nutrition research: January 2004 2 Highlights of Tufts University nutrition research: January 2004 3 Highlights of Tufts University nutrition research: January 2004 4

'Kissing' RNA and HIV-1: Unraveling the details Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory Highlights of Tufts University nutrition research: January 2004 Largest brain repair initiative in MS will speed strategies to restore nerve function

..., 2005 -- Results from a Phase 2 rheumatoid arthri...f golimumab (CNTO 148), a fully-human anti-TNF-alp...dpoint of the study. In this dose-ranging trial, ...o severely active RA treated with golimumab and me...

...s with the University of Florida and the Californi...ain of genetically modified mice that allow scient...erapies for Alzheimer's disease.......The developm...cess medical journal PloS Medicine, has helped sci...

It sounds like science fiction: simply swallowing a pill, or eating a specific food supplement, could permanently change your behaviour for the better, or reverse diseases such as schizophrenia, Hunti

...ardiology researchers at Cedars-Sinai Medical Cent...s virus engineered to carry a beneficial, mutant g...y of the gene's protein product that protects agai...the amount of plaque was significantly reduced, as...

Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 2 Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 3 Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial 4 Scientists engineer mice to mimic Alzheimer's therapy 2 The food you eat could change your genes 2 The food you eat could change your genes 3 Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 2 Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque 3

Centocor & Schering-Plough next generation biologic promising in Phase 2 rheumatoid arthritis trial Scientists engineer mice to mimic Alzheimer's therapy The food you eat could change your genes Studies show apo A-I Milano gene transfer and antibody therapy cut atherosclerotic plaque